News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
147 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (18719)
Month
January (2987)
February (3289)
March (3625)
April (3424)
May (3732)
June (3551)
July (2687)
August (3042)
September (3454)
October (3101)
November (3075)
December (2362)
Day
1 (101)
5 (146)
6 (147)
7 (131)
8 (90)
11 (123)
12 (163)
13 (126)
14 (128)
15 (96)
18 (149)
19 (147)
20 (146)
21 (138)
22 (86)
25 (148)
26 (159)
27 (152)
28 (194)
29 (117)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
5
6
7
8
11
12
13
14
15
18
19
20
21
22
25
26
27
28
29
Lone Star Bio
Lexicon Pharma Announces The Validation By The European Medicines Agency Of The Marketing Authorization Application For Telotristat Etiprate For The Treatment Of Carcinoid Syndrome
July 19, 2016
·
4 min read
Policy
Depomed Announces Patent Trial And Appeal Board Denial Of Inter Partes Review Of NUCYNTA Patent
July 19, 2016
·
2 min read
FDA
Eli Lilly Release: U.S. FDA Expands Indication For Type 2 Diabetes Treatment Synjardy (Empagliflozin/Metformin Hydrochloride) To Include Treatment-Naïve Adults
July 19, 2016
·
16 min read
Profounda, Inc. Launches Second Product This Year, Rhinase, The Only Non-Prescription, Wetting-Agent Based Nasal Moisturizer That Will Help People With Nasal Dryness Associated With Allergies, Low Humidity, Stuffy Nose And Nosebleeds
July 19, 2016
·
2 min read
FDA
Allergan And Adamas Pharmaceuticals Announce New Expanded Indication For NAMZARIC (Memantine And Donepezil Hydrochlorides) Extended Release For The Treatment Of Moderate To Severe Alzheimer’s Disease
July 19, 2016
·
11 min read
Pharm Country
Unilife Submits Plan To Regain Compliance With NASDAQ Requirements
July 19, 2016
·
2 min read
Pharm Country
Egalet Announces Issuance Of Two New U.S. Patents For Guardian Technology
July 19, 2016
·
3 min read
FDA
Ajanta Pharma Announces The Approval And Launch Of Omeprazole And Sodium Bicarbonate Capsules
July 19, 2016
·
1 min read
ProMis Neurosciences Announces New Program To Identify Novel ALS Disease Targets On Toxic Strains Of Protein TDP43
July 19, 2016
·
3 min read
FDA
Eisai Inc. And Arena Announce FDA Approval Of BELVIQ XR (Lorcaserin Hcl) Extended-Release Tablets
July 19, 2016
·
12 min read
1 of 15
Next